Divisions
Infectious Diseases
Division Faculty
Research
Laboratory Research
Patient-Oriented Research
International Health Research
Pediatric Infectious Diseases Fellowship
Patient Care
Contact Us

Institute for Global HealthInstitute for Global Health

The Vanderbilt Institute for Global Health is committed to advancing health and development in resource-limited regions. With projects in Africa, Asia, Latin America, and the Caribbean, our approach is grounded in research, training, and service that is appropriate to the developing world.

VIGH faculty and staff provide leadership and expertise in the establishment of sustainable, scalable health and development programs through innovative multidisciplinary approaches rooted in strong academic research and training, and pragmatic partnerships.

Sten Vermund, M.D., Ph.D.

Sten Vermund, M.D., Ph.D. is the inaugural Amos Christie Chair in Global Health and director of the university-wide Vanderbilt Institute for Global Health. He is also professor of Pediatrics, Medicine, Obstetrics and Gynecology, and Preventive Medicine at Vanderbilt University School of Medicine.

Sten Vermund, M.D.Dr. Vermund received his medical degree from Albert Einstein College of Medicine and completed his pediatric internship and residency, as well as a fellowship in epidemiology, at New York-Presbyterian Hospital. He also earned a master's degree in science at the London School of Hygiene and Tropical Medicine, a diploma in Public Health from the Royal Institute of Public Health and Hygiene in London and a doctoral degree in epidemiology from Columbia University in New York. After serving on the faculty of Columbia University and Einstein College of Medicine, Dr. Vermund directed the Vaccine Trials and Epidemiology Branch at the Division of AIDS (NIAID/NIH). In 1994, he became Chairman of the Department of Epidemiology, and Director of the Division of Geographic Medicine at the University of Alabama in Birmingham.

While at VIGH, he has founded two organizations to spearhead HIV prevention, care and treatment in Africa. Significant scientific discoveries for the treatment and prevention of HIV emerged under his leadership of the HIV Prevention Trials Network (HPTN) for the National Institutes of Health. Dr. Vermund's research interests lie in infectious disease control and prevention with a focus on developing countries and underserved areas of the southeastern U.S.

In 2010, Vermund received the Albert Einstein College of Medicine Lifetime Alumni Achievement Award and received the Faculty Award for Teaching Excellence in Global Health from the Global Health Education Consortium (GHEC) in 2011. This year he received the Douglas K. Richardson Award from the Society for Pediatric Research. The award recognizes Vermund’s “substantive contributions to pediatric health care and health services research.”

Due to years of extensive training, research and service activities worldwide and 15 years of mentorship experience with FIC programs, Dr. Vermund enjoys a substantial network of international collaborators comprised of former students, fellows, AITRP, IMCHRT, FICRS-F, and ICOHRTA trainees.

Dr. Vermund's current-funded grants include the following projects: Mozambique and Nigeria (PEPFAR-HIV care and treatment), Zambia HIV/AIDS -related training (AITRP, via a partnership with CDC-PEPFAR and Fogarty/NIH), Pakistan/Bangladesh/India (HIV risk reduction in injection drug users, cervical cancer screening among HIV-infected women, HIV/AIDS -related training), and China (HIV/AIDS related training, multicomponent HIV prevention trials, HIV/AIDS epidemic modeling and, HIV incidence surveillance.



 
Vanderbilt University School Of Medicine
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Department of Pediatrics | 2200 Children's Way | Nashville, Tenn. 37232 | 615.936.1000
© 2014 Vanderbilt University School of Medicine
Monroe Carrell Jr. Children's Hospital at Vanderbilt